Risk mechanisms in hypertensive heart disease

被引:137
作者
Frohlich, ED [1 ]
机构
[1] Alton Ochsner Med Fdn & Ochsner Clin, New Orleans, LA 70121 USA
关键词
left ventricular hypertrophy; coronary heart disease; coronary hemodynamics; fibrosis; sudden death; risk;
D O I
10.1161/01.HYP.34.4.782
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
In this report, some of the underlying pathophysiological alterations associated with the independent risk from hypertensive heart disease and left ventricular hypertrophy are discussed. Emphasized are the classically described coronary hemodynamic alterations of decreased coronary blood flow and flow reserve with increased coronary vascular resistance and minimal coronary resistance; more recent concepts of endothelial dysfunction are emphasized. Additionally, increased collagen deposition within the ventricular walls and perivascularly participates importantly. These changes are exacerbated by the aging process and perhaps by increased dietary salt intake. Consequences of these functional and structural changes include further endothelial dysfunction, impairment of coronary hemodynamics, and ventricular contractile function (diastolic as well as systolic). The clinical consequences of these alterations are angina pectoris (with or without atherosclerosis). myocardial infarction, cardiac failure, lethal dysrhythmias, and sudden cardiac death. Thus, not all that is clinically recognized as "left ventricular hypertrophy" is true myocytic hypertrophy with structural remodeling: other important comorbid changes occur that directly affect risk, including ventricular fibrosis, impaired coronary hemodynamics, and endothelial dysfunction.
引用
收藏
页码:782 / 789
页数:8
相关论文
共 117 条
[31]   CARDIAC-HYPERTROPHY IN HYPERTENSION [J].
FROHLICH, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (13) :831-833
[32]   MEDICAL PROGRESS - THE HEART IN HYPERTENSION [J].
FROHLICH, ED ;
APSTEIN, C ;
CHOBANIAN, AV ;
DEVEREUX, RB ;
DUSTAN, HP ;
DZAU, V ;
FAUADTARAZI, F ;
HORAN, MJ ;
MARCUS, M ;
MASSIE, B ;
PFEFFER, MA ;
RE, RN ;
ROCCELLA, EJ ;
SAVAGE, D ;
SHUB, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (14) :998-1008
[33]  
Frohlich ED, 1997, ADV EXP MED BIOL, V432, P253
[34]  
FROHLICH ED, 1991, HYPERTENSION, V18, P2
[35]  
FROHLICH ED, 1991, ADV EXP MED BIOL, V308, P175
[36]   THE 1ST PAGE,IRVINE,H. LECTURE THE MOSAIC OF HYPERTENSION - PAST, PRESENT AND FUTURE [J].
FROHLICH, ED .
JOURNAL OF HYPERTENSION, 1988, 6 :S2-S11
[37]   CHANGES IN CARDIOVASCULAR MASS, LEFT-VENTRICULAR PUMPING ABILITY AND AORTIC DISTENSIBILITY AFTER CALCIUM-ANTAGONISTS IN WISTAR-KYOTO AND SPONTANEOUSLY HYPERTENSIVE RATS [J].
FROHLICH, ED ;
SASAKI, O ;
CHIEN, YW ;
ARITA, M .
JOURNAL OF HYPERTENSION, 1992, 10 (11) :1369-1378
[38]   Current clinical pathophysiologic considerations in essential hypertension [J].
Frohlich, ED .
MEDICAL CLINICS OF NORTH AMERICA, 1997, 81 (05) :1113-+
[39]  
FROHLICH ED, 1991, HYPERTENSION, V18, P133
[40]   Influence of nitric oxide and angiotensin II on renal involvement in hypertension [J].
Frohlich, ED .
HYPERTENSION, 1997, 29 (01) :188-193